GCP R3: GCP is evolving, are you? The ICH has released the E6(R3) revision of Good Clinical Practice (GCP), and it marks a turning point. With this update, the rules of clinical evidence have changed, and if you're working on ...
The MDR deadline extension is not a pause. It’s a strategic opportunity – but only if you act early. Back in early 2024, the European Commission granted more time for companies to align with Regulation (EU) 2017/745 (MDR) – particularly ...
The extension is here, but it's not a safety net. Learn how to move fast, stay compliant, and protect your market share. With Regulation (EU) 2023/607, the European Commission has introduced a critical extension to MDR deadlines for legacy devices ...
Artificial Intelligence (AI) and automated systems are transforming the clinical research sector, improving data collection and analysis, optimizing decision-making processes, and reducing study time and costs. However, while these technologies offer valuable support, it is essential to understand that they ...
Clinical research is a fundamental pillar for the progress of medicine and the development of new therapies. The role of the Ethics Committees (ECs), independent bodies responsible for evaluating and approving trials, is a crucial element in ensuring ethical and ...
In recent years, the issue of gender equality has taken on central importance. Companies are actively working to ensure equal opportunities, pay equity, and inclusive environments where every employee can fully realize their potential. At We4 Clinical Research, we firmly …